Skip to main content
Contribution to Book
The Lazarus Effect: The (RED) Campaign, and Creative Capitalism
Incentives for Global Public Health: Patent Law and Access to Essential Medicines (2010)
  • Matthew Rimmer, Australian National University College of Law
Abstract

4,400 people die every day of AIDS in sub-Saharan Africa. Treatment exists. In about 60 days, a patient can go from here to here. We call this transformation the Lazarus Effect. It is the result of two pills a day taken by a HIV/AIDS patient for about 60 days. Learn more about how you can help give people the chance of life and joinred.com."

The Lazarus Effect video, the (RED) Campaign.

This Chapter explores how a number of non-government organizations, charities, and philanthropists have promoted 'grants' as a means of stimulating investment in research and development into neglected diseases. Each section considers the nature of the campaign; the use of intellectual property rights, such as trade marks; and the criticisms made of such endeavors. Section II looks at the (RED) Campaign, which is designed to boost corporate funding and consumer support for the Global Fund. Section III examines the role of the Gates Foundation in funding research and development in respect of infectious diseases. It explores the championing by Bill Gates of 'creative capitalism'. Section IV considers the part of the Clinton Foundation in the debate over access to essential medicines. The Chapter concludes that, despite their qualities, such marketing initiatives fail to address the underlying inequalities and injustices of international patent law.

Keywords
  • Access to Medicines,
  • Trade Mark Law,
  • Celebrity Rights,
  • the (RED) Campaign,
  • the Gates Foundation,
  • the Clinton Foundation,
  • creative capitalism
Publication Date
December, 2010
Editor
Pogge, Matthew Rimmer, and Kim Rubenstein
Publisher
Cambridge University Press
Series
Connecting International with Public Law
Citation Information
Matthew Rimmer. "The Lazarus Effect: The (RED) Campaign, and Creative Capitalism" CambridgeIncentives for Global Public Health: Patent Law and Access to Essential Medicines Vol. 2 (2010)
Available at: http://works.bepress.com/matthew_rimmer/68/